tirzepatide product for Men's Weight Tirzix (Tirzepatide) Injection (2.5 mg/0.5

Start your free assessment

Food Preservation 5.3.10

This drug, primarily used for diabetes management, has shown promising results in weight loss and metabolic health improvement

3 Ask your prescriber about the cardiovascular indication if eligible If you have established cardiovascular disease (prior heart attack, stroke, or symptomatic peripheral arterial disease) and are overweight or obese, Wegovy's cardiovascular indication may be coverable with PA even on plans that excluded weight-loss use

Your doctor may start you on antiarrhythmic drugs to normalise your heart rate and prevent arrhythmia episodes

Tirzepatide has now been approved for chronic weight management by the FDA in 2023 following the clinical trials data